Moshe Alafi Insider Profile

4 Followers
Moshe Alafi, Ten Percent Owner at Intra-Cellular Therapies, holds 3.60M shares in Intra-Cellular Therapies (Ticker: ITCI), holds 2.33M shares in Stereotaxis (Ticker: STXS). Most recently, Moshe Alafi Bought ― shares of Intra-Cellular Therapies on Oct 03, 2017 for an estimated value of 4.00M.
tipranks
Moshe Alafi

Moshe Alafi
Intra-Cellular Therapies (ITCI)
Ten Percent Owner

Ranked #144 out of 99,335 Corporate Insiders

Profitable Transactions

78%
7 out of 9 Profitable Transactions

Average Return

+145.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$333M
98.69%
1.31%
A breakdown of Moshe Alafi's holdings

Insider Roles

Intra-Cellular Therapies
(ITCI)
Ten Percent Owner
Stereotaxis
(STXS)
Ten Percent Owner
Roles that Moshe Alafi holds in companies

Most Profitable Insider Trade

Stock:
Intra-Cellular Therapies
(ITCI)
Rating:Informative Buy
Date:Nov 28, 2014 - Nov 28, 2015
Return:+308.90%
The most profitable trade made by Moshe Alafi

Moshe Alafi's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Intra-Cellular Therapies
Oct 03, 2017
Ten Percent Owner
Informative Buy
4.00M
$328.30M
Stereotaxis
Ten Percent Owner
$4.36M
List of latest transactions for each holding click on a transaction to see Moshe Alafi's performance on stock

Moshe Alafi insider profile FAQ

What is the percentage of profitable transactions made by Moshe Alafi?
The percentage of profitable transactions made by Moshe Alafi is 78%.
    What is the average return per transaction made by Moshe Alafi?
    The average return per transaction made by Moshe Alafi is 145.10%.
      What stocks does Moshe Alafi hold?
      Moshe Alafi holds: ITCI, STXS stocks.
        What was Moshe Alafi’s latest transaction?
        Moshe Alafi latest transaction was an Informative Buy of $4.00M.
          What was Moshe Alafi's most profitable transaction?
          Moshe Alafi’s most profitable transaction was an Informative Buy of ITCI stock on November 28, 2014. The return on the trade was 308.90%.
            What is Moshe Alafi's role in Intra-Cellular Therapies?
            Moshe Alafi's role in Intra-Cellular Therapies is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.